SmithKline CEO Garnier to head OTC and pharmaceuticals businesses.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE CHIEF OPERATING OFFICER GARNIER TO OVERSEE OTC AND Rx BUSINESSES at SmithKline Beecham, the company announced Oct. 2. J.P. Garnier was appointed chief operating officer and pharmaceuticals and consumer healthcare president. The decision to combine responsibility for both the consumer and pharmaceutical businesses represents "a major step in SB's drive toward leadership through implementation of an integrated healthcare strategy," the company said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning